CorDx’s Influenza A+B & COVID-19 Ag Combo Test is an in vitro immuno-chromatographic assay for the qualitative and differential detection of nucleocapsid protein antigen from influenza A (including the subtype H1N1), influenza B, and SARS-CoV-2 in nasopharyngeal (NP) swab specimens. The test provides clinicians with preliminary qualitative results of a COVID-19 or influenza infection present in a patient. This test provides only a preliminary test result. Any reactive specimen with the influenza A+B and COVID-19 Ag Combo Test must be confirmed with alternative testing methods and clinical findings.

Download
Clinical Study
IFU
CE Certificate